Wockhardt Limited (NSE:WOCKPHARMA)

Wockhardt Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	2,170	1,120	5,050	900	3,700
Short-Term Investments	4,630	4,760	180	260	120
Cash & Short-Term Investments	6,800	5,880	5,230	1,160	3,820
Cash Growth	15.65%	12.43%	350.86%	-69.63%	44.15%
Accounts Receivable	5,880	6,610	6,180	7,970	9,680
Receivables	5,880	6,610	6,180	7,970	9,680
Inventory	8,900	7,290	6,420	6,590	7,700
Restricted Cash	-	-	40	10	50
Other Current Assets	5,390	5,910	3,970	6,350	4,640
Total Current Assets	26,970	25,690	21,840	22,080	25,890
Property, Plant & Equipment	22,890	22,310	23,090	24,360	28,600
Goodwill	10,280	9,770	9,530	9,450	8,910
Other Intangible Assets	18,530	15,610	13,410	12,000	10,530
Long-Term Deferred Tax Assets	4,770	5,490	5,790	6,080	5,730
Other Long-Term Assets	2,710	2,480	2,830	2,860	2,770
Total Assets	86,150	81,350	76,490	76,830	82,430

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	5,630	5,920	7,660	8,670	9,210
Accrued Expenses	1,070	960	1,160	1,280	1,190
Short-Term Debt	4,380	4,960	8,320	13,300	10,340
Current Portion of Long-Term Debt	1,690	1,520	3,890	3,330	4,730
Current Portion of Leases	700	670	740	710	690
Current Income Taxes Payable	60	150	100	220	180
Current Unearned Revenue	830	1,850	1,040	730	680
Other Current Liabilities	1,860	4,390	5,000	6,110	5,050
Total Current Liabilities	16,220	20,420	27,910	34,350	32,070
Long-Term Debt	15,180	12,110	8,910	2,240	3,550
Long-Term Leases	380	950	1,700	2,260	2,670
Long-Term Unearned Revenue	640	660	720	780	-
Pension & Post-Retirement Benefits	280	200	190	170	210
Long-Term Deferred Tax Liabilities	370	350	350	320	280
Other Long-Term Liabilities	270	90	90	90	1,630
Total Liabilities	33,340	34,780	39,870	40,210	40,410

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	810	810	770	720	720
Additional Paid-In Capital	22,400	22,390	12,610	7,990	7,960
Retained Earnings	7,400	4,640	5,150	9,830	15,480
Comprehensive Income & Other	18,130	15,030	14,400	14,340	13,670
Total Common Equity	48,740	42,870	32,930	32,880	37,830
Minority Interest	3,410	3,040	3,030	3,080	3,530
Shareholders' Equity	52,810	46,570	36,620	36,620	42,020
Total Liabilities & Equity	86,150	81,350	76,490	76,830	82,430

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	22,330	20,210	23,560	21,840	21,980
Net Cash (Debt)	-15,530	-14,330	-18,330	-20,680	-18,160
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-95.48	-91.33	-127.07	-143.55	-150.63
Filing Date Shares Outstanding	162.49	162.49	153.4	144.09	144.06
Total Common Shares Outstanding	162.49	162.49	153.4	144.09	144.06
Working Capital	10,750	5,270	-6,070	-12,270	-6,180
Book Value Per Share	299.95	263.84	214.67	228.19	262.60
Tangible Book Value	19,930	17,490	9,990	11,430	18,390
Tangible Book Value Per Share	122.65	107.64	65.12	79.33	127.66
Land	60	200	200	200	630
Buildings	6,840	6,540	6,450	6,420	7,480
Machinery	30,630	29,330	28,630	28,370	30,250
Construction In Progress	6,710	5,130	4,340	4,140	3,890

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error